$NPHC
Post# of 102231
10 Different Drugs in Testing
http://www.receptopharm.com/drug_development/pipeline.php
Nutra Pharma's RPI-78M Granted Orphan Drug Status by the US Food and Drug Administration
"We expect to begin the trial in FY-2017 for a Phase I/II trial for the use of RPI–78M in the treatment of Pediatric Multiple Sclerosis. "
University of Maryland,production of RPI-78M for the planned upcoming clinical trials in Pediatric Multiple Sclerosis "
Share Structure
Market Value1 $987,446 a/o Oct 18, 2017
Authorized Shares 2,000,000,000 a/o Apr 17, 2017
Outstanding Shares 1,645,743,000 a/o Oct 04, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 1,469,627,212 a/o Sep 29, 2017
Par Value .001
Standard Registrar and Transfer Co., Inc.
http://www.otcmarkets.com/stock/nphc/profile
https://youtu.be/QhAnMjLBQ5Y?t=983 CEO INTERVIEW
Quote:
MedGift @MedGift Oct 13
Former NFL Safety- Jack Brewer discussion his Medical Relief Fund and MedGift on Fox news today
BREWER ABOUT A MINUTE IN
https://video.foxnews.com/a2ae8e2b-1b0f-46d6-...8b1c812a09
https://twitter.com/JackBrewerBSI/status/918925819103367168
https://twitter.com/JackBrewerBSI/status/914953914486870027
Quote:
Nutra Pharma @nutrapharma
"Woke up with a headache, can't sleep & my neck is aching. Thank you Nyloxin!"
Former #NFL safety @jackbrewerbsi... fb.me/2NBsRO0FG
BREWER https://twitter.com/JackBrewerBSI
HPMM PCLI ZMRK OXIHF IKTO VGLS RMRK APRU NWPN SNRY MEDH